These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31671185)

  • 1. Making the cut(s): how Cas12a cleaves target and non-target DNA.
    Swarts DC
    Biochem Soc Trans; 2019 Oct; 47(5):1499-1510. PubMed ID: 31671185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
    Swarts DC; Jinek M
    Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bridge helix of Cas12a imparts selectivity in cis-DNA cleavage and regulates trans-DNA cleavage.
    Parameshwaran HP; Babu K; Tran C; Guan K; Allen A; Kathiresan V; Qin PZ; Rajan R
    FEBS Lett; 2021 Apr; 595(7):892-912. PubMed ID: 33523494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized protocols for the characterization of Cas12a activities.
    Martin L; Rostami S; Rajan R
    Methods Enzymol; 2023; 679():97-129. PubMed ID: 36682874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mg
    Son H; Park J; Hwang I; Jung Y; Bae S; Lee S
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34853172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of target specificity of CRISPR-Cas12a by using a chimeric DNA-RNA guide.
    Kim H; Lee WJ; Oh Y; Kang SH; Hur JK; Lee H; Song W; Lim KS; Park YH; Song BS; Jin YB; Jun BH; Jung C; Lee DS; Kim SU; Lee SH
    Nucleic Acids Res; 2020 Sep; 48(15):8601-8616. PubMed ID: 32687187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Cme and Yme thermostable Cas12a orthologs.
    Fuchs RT; Curcuru JL; Mabuchi M; Noireterre A; Weigele PR; Sun Z; Robb GB
    Commun Biol; 2022 Apr; 5(1):325. PubMed ID: 35388146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a).
    Singh D; Mallon J; Poddar A; Wang Y; Tippana R; Yang O; Bailey S; Ha T
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5444-5449. PubMed ID: 29735714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis for the Inhibition of CRISPR-Cas12a by Anti-CRISPR Proteins.
    Zhang H; Li Z; Daczkowski CM; Gabel C; Mesecar AD; Chang L
    Cell Host Microbe; 2019 Jun; 25(6):815-826.e4. PubMed ID: 31155345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct observation of DNA target searching and cleavage by CRISPR-Cas12a.
    Jeon Y; Choi YH; Jang Y; Yu J; Goo J; Lee G; Jeong YK; Lee SH; Kim IS; Kim JS; Jeong C; Lee S; Bae S
    Nat Commun; 2018 Jul; 9(1):2777. PubMed ID: 30018371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a.
    Sundaresan R; Parameshwaran HP; Yogesha SD; Keilbarth MW; Rajan R
    Cell Rep; 2017 Dec; 21(13):3728-3739. PubMed ID: 29281823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects.
    Murugan K; Seetharam AS; Severin AJ; Sashital DG
    J Biol Chem; 2020 Apr; 295(17):5538-5553. PubMed ID: 32161115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.
    Chen JS; Ma E; Harrington LB; Da Costa M; Tian X; Palefsky JM; Doudna JA
    Science; 2018 Apr; 360(6387):436-439. PubMed ID: 29449511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets.
    Nalefski EA; Kooistra RM; Parikh I; Hedley S; Rajaraman K; Madan D
    Nucleic Acids Res; 2024 May; 52(8):4502-4522. PubMed ID: 38477377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas12a targeting of ssDNA plays no detectable role in immunity.
    Marino ND; Pinilla-Redondo R; Bondy-Denomy J
    Nucleic Acids Res; 2022 Jun; 50(11):6414-6422. PubMed ID: 35670674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
    Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
    Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-Activated CRISPR/Cas12a Nanorobots Operating in Living Cells.
    Yuan A; Sha R; Xie W; Qu G; Zhang H; Wang H; Le XC; Jiang G; Peng H
    J Am Chem Soc; 2024 Oct; 146(39):26657-26666. PubMed ID: 39183441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single molecule methods for studying CRISPR Cas9-induced DNA unwinding.
    Okafor IC; Choi J; Ha T
    Methods; 2022 Aug; 204():319-326. PubMed ID: 34767923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad-spectrum enzymatic inhibition of CRISPR-Cas12a.
    Knott GJ; Thornton BW; Lobba MJ; Liu JJ; Al-Shayeb B; Watters KE; Doudna JA
    Nat Struct Mol Biol; 2019 Apr; 26(4):315-321. PubMed ID: 30936531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.